|
Aug 1
|
FOLD Q2 Earnings Miss Mark, Revenues Beat on Higher Product Sales
|
|
Jul 31
|
Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises
|
|
Jul 31
|
UTHR Q2 Earnings Miss Estimates, Higher Tyvaso Sales Aid Revenues Y/Y
|
|
Jul 31
|
Immunocore to report second quarter 2025 financial results and host call on August 7, 2025
|
|
Jul 30
|
Alkermes Q2 Earnings Beat Estimates, Proprietary Drugs Aid Sales
|
|
Jul 24
|
Wall Street Analysts See a 72.34% Upside in Immunocore (IMCR): Can the Stock Really Move This High?
|
|
Jul 1
|
Biogen Begins Phase III Felzartamab Study for Third Kidney Disease
|
|
Jun 30
|
Er-Kim Announces Exclusive Agreement with Immunocore to Distribute KIMMTRAK in Turkey, and the MENA, Caucasus and CIS Regions
|
|
Jun 25
|
Strength Seen in Kamada (KMDA): Can Its 9.5% Jump Turn into More Strength?
|
|
Jun 25
|
Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag
|
|
Jun 24
|
FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer
|
|
Jun 2
|
Wall Street Analysts Think Immunocore (IMCR) Could Surge 65.22%: Read This Before Placing a Bet
|
|
Jun 2
|
Immunocore to present at the 2025 Jefferies Global Healthcare Conference
|
|
May 23
|
Is it a Good Idea to Invest in Immunocore Stock Right Now?
|
|
May 7
|
Compared to Estimates, Immunocore (IMCR) Q1 Earnings: A Look at Key Metrics
|
|
Feb 20
|
Lilly’s former M&A chief scours the landscape for potential deals as Immunocore’s new CFO
|
|
Feb 19
|
Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025
|
|
Feb 17
|
Immunocore Gears Up to Report Q4 Earnings: Is a Beat in Store?
|
|
Jan 2
|
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development
|
|
Sep 29
|
Immunocore Holdings plc (IMCR): Worst 52-Week Low Stock to Buy Now
|